What is the average price target for KODIAK SCIENCES INC (KOD) stock?
11 analysts have analysed KOD and the average price target is 36.21 USD. This implies a price increase of 2.2% is expected in the next year compared to the current price of 35.43.
KODIAK SCIENCES INC (KOD) Forecast, Price Target & Analyst Ratings
NASDAQ:KOD • US50015M1099
Current stock price
35.43 USD
-1.57 (-4.24%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KODIAK SCIENCES INC (KOD).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 12, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.05
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$36.21
Upside
+ 2.20%
From current price of $35.43 to mean target of $36.21, Based on 11 analyst forecasts
Low
$14.14
Median
$39.27
High
$52.50
Price Target Revisions
1 Month
0.00%
3 Months
60.32%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for KOD. The average price target is 36.21 USD. This implies a price increase of 2.2% is expected in the next year compared to the current price of 35.43.
The average price target has been revised upward by 60.32% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
KOD was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about KOD.
In the previous month the buy percentage consensus was at a similar level.
KOD was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-27 | UBS | Maintains | Buy -> Buy |
| 2026-03-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-07 | UBS | Initiate | Buy |
| 2025-11-17 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-11 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-10-24 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-23 | LifeSci Capital | Initiate | Outperform |
| 2025-10-06 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-09-25 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2025-09-22 | Jefferies | Initiate | Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-08-14 | Barclays | Maintains | Underweight -> Underweight |
| 2025-08-14 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-09 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-15 | Barclays | Maintains | Underweight -> Underweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-24 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-05 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-04-04 | UBS | Maintains | Neutral -> Neutral |
| 2024-04-01 | Barclays | Maintains | Underweight -> Underweight |
| 2023-12-21 | UBS | Maintains | Neutral -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.05
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -24.45%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-2.75%
Next Earnings Summary
KOD is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -1.05 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 231.59% | N/A 66.46% | N/A 61.58% | N/A 39.89% | N/A 23.64% | N/A 14.92% | ||||||||||
| EBITDA YoY % growth | -16.89M | -24.97M -47.84% | -25.88M -3.64% | -48.65M -87.98% | -135.53M -178.58% | -266.05M -96.30% | -337.58M -26.89% | -259.023M 23.27% | -168.139M 35.09% | N/A -37.30% | N/A -15.21% | N/A 0.83% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.15M | -25.52M -48.80% | -26.37M -3.33% | -49.19M -86.54% | -136.01M -176.50% | -267.05M -96.35% | -341.38M -27.83% | -277.321M 18.76% | -186.849M 32.62% | N/A -29.56% | N/A -9.94% | N/A -0.87% | N/A 48.29% | N/A 59.25% | N/A 324.72% | N/A 151.33% | N/A 49.71% | N/A 25.66% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.25 40.14% | -2.89 -131.20% | -5.15 -78.20% | -6.39 -24.08% | -4.96 22.38% | -3.36 32.26% | N/A -26.75% | N/A 11.59% | N/A 6.72% | N/A 60.03% | N/A 58.99% | N/A 296.49% | N/A 144.64% | N/A 47.45% | N/A 24.26% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.05 -24.45% | -0.83 24.02% | -0.87 15.67% | -0.94 19.03% | -1.03 1.45% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -64.64M -135.32% | -72.059M -37.07% | -72.868M -57.34% | -77.807M -60.20% | N/A |
| EBIT Q2Q % growth | -62.691M -35.76% | -65.241M -14.11% | -66.928M -20.57% | -70.941M -13.78% | -75.223M -19.99% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-1.49%
EPS Next 5 Year
12.83%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-10.91%
EBIT Next 5 Year
N/A
KODIAK SCIENCES INC / KOD Forecast FAQ
When does KODIAK SCIENCES INC (KOD) report earnings?
KODIAK SCIENCES INC (KOD) will report earnings on 2026-05-12.
What are the consensus estimates for KOD stock next earnings?
The consensus EPS estimate for the next earnings of KODIAK SCIENCES INC (KOD) is -1.05 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for KODIAK SCIENCES INC (KOD) stock?
The consensus rating for KODIAK SCIENCES INC (KOD) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.